BIFIDO Co., Ltd. (KOSDAQ:238200)
South Korea · Delayed Price · Currency is KRW 2,730.00
+25.00 (0.92%)
At close: Aug 21, 2026
BIFIDO Market Cap
BIFIDO has a market cap or net worth of 22.33 billion as of August 21, 2026. Its market cap has decreased by -32.26% in one year.
Market Cap
22.33B
Enterprise Value
27.03B
Revenue
17.23B
Ranking
n/a
PE Ratio
9.78
Stock Price
2,730.00
ChartMarket Cap Chart
Since December 26, 2018, BIFIDO's market cap has decreased from 149.29B to 22.33B, a decrease of -85.04%. That is a compound annual growth rate of -21.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 22.33B | -10.93% |
| Dec 30, 2025 | 25.07B | 4.07% |
| Dec 30, 2024 | 24.09B | -45.16% |
| Dec 28, 2023 | 43.93B | -36.82% |
| Dec 29, 2022 | 69.53B | -22.02% |
| Dec 30, 2021 | 89.16B | -4.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Korea Arlico Pharm | 36.17B |
| Kyung Nam Pharm | 30.12B |
| HLscience | 28.11B |
| Pharmsville | 27.98B |
| Baskhanbio Pharma | 25.27B |
| Daesung Microbiological Labs. | 23.45B |
| Seoul Pharma | 23.23B |
| Hurum | 21.70B |